title: Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
authors.affiliation: Smith Kline and French Laboratories, Department of Immunology, King of Prussia, PA 19406.
authors.forename: D E
authors.initials: DE
authors.lastname: Griswold
authors.forename: J W
authors.initials: JW
authors.lastname: Egan
authors.forename: C Q
authors.initials: CQ
authors.lastname: Earl
authors.forename: L M
authors.initials: LM
authors.lastname: Hillegass
authors.forename: P J
authors.initials: PJ
authors.lastname: Marshall
authors.forename: E F
authors.initials: EF
authors.lastname: Smith
mesh_terms: D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009203:Myocardial Infarction / Q000473:pathology / Q000517:prevention & control; D015428:Myocardial Reperfusion Injury / Q000473:pathology / Q000517:prevention & control*; D009504:Neutrophils / Q000187:drug effects / Q000473:pathology; D010648:Phenylacetates / Q000494:pharmacology*; D011450:Prostaglandin Endoperoxides, Synthetic / Q000037:antagonists & inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D010648:Phenylacetates; D011450:Prostaglandin Endoperoxides, Synthetic; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D013449:Sulfonamides; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; C051762:daltroban